Institutional investors control 13.85% of the outstanding shares in SYN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2017, these large investors purchased a net $600.4 thousand shares.
Other institutional | 9.69% |
Mutual fund holders | 4.16% |
Individual stakeholders | 13.66% |